Small Pharma’s Q2 2023 Financial Results, ‘Ultra Short-Acting Psychedelic Program’ Underway – Small Pharma (OTC:DMTTF)
Small Pharma Inc. DMTTF, a biotech company developing short-acting psychedelic-assisted therapies for diverse mental health disorders, reported its financial results for the three and six months ended August 31, 2022.…